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WHAT’S KNOWN ON THIS SUBJECT: Moderately preterm-born
children (32–35
6/7 weeks’ gestation) are at risk for both neonatal
morbidities after birth and developmental delays in early
childhood. It is unknown whether neonatal morbidities contribute
to the developmental delays of this particular group.
WHAT THIS STUDY ADDS: Of all neonatal morbidities commonly
seen in moderately preterm-born children, only hypoglycemia
increased the risk of developmental delay after moderately
preterm birth. A concerted effort to prevent hypoglycemia after
birth might enhance developmental outcome in this group.
abstract
BACKGROUND AND OBJECTIVE: Children born moderately preterm
(32–35
6/7 weeks’ gestation) are at increased risk of both neonatal
morbidities and developmental delays in early childhood. It is un-
known whether neonatal morbidities contribute to the increased risk
of developmental delay. The objective of this study was to determine
the effect of neonatal morbidities after moderately preterm birth on
development at preschool age.
METHODS: In a community-based, stratiﬁed cohort, parents of 832
moderately preterm children born in 2002 or 2003 completed the Ages
and Stage Questionnaire when their child was 43 to 49 months old. Data
on Apgar scores, asphyxia, tertiary NICU admission, hospital transfer,
circulatory insufﬁciency, hypoglycemia, septicemia, mechanical ventila-
tion,continuouspositiveairwaypressure,apneas,caffeinetreatment,
and hyperbilirubinemia were obtained from medical records. We
assessed associations of neonatal characteristics with developmental
delay, adjusted for gender, small-for-gestational-age status, gestational
age, and maternal education.
RESULTS: Hypoglycemia and asphyxia were associated with develop-
mental delay; odds ratios (ORs) were 2.42 (95% conﬁdence interval
[CI]: 1.23–4.77) and 3.18 (95% CI: 1.01–10.0), respectively. Tertiary NICU
admission and hyperbilirubinemia had positive but statistically bor-
derline nonsigniﬁcant associations with developmental delay: ORs
were 1.74 (95% CI: 0.96–3.15) and 1.52 (95% CI: 0.94–2.46), respectively.
No other neonatal morbidities were associated with developmental
delay. In multivariate analyses, only hypoglycemia was associated
with developmental delay (OR: 2.19; 95% CI: 1.08–4.46).
CONCLUSIONS: In moderately preterm-born children, only hypoglycemia
increased the risk of developmental delay at preschool age. A concerted
effort to prevent hypoglycemia might enhance developmental outcome in
this group. Pediatrics 2012;130:e265–e272
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(32–35
6/7 weeks’ gestation)1,2 have a
relatively high rate of neonatal morbid-
ities.3Theseneonatalmorbiditiesinclude
asphyxia, respiratory insufﬁciency, cir-
culatory insufﬁciency, septicemia, hy-
poglycemia, hyperbilirubinemia, apnea,
hypothermia, and feeding problems.3–6
Some of these morbidities are severe
enough to warrant admission to a ter-
tiaryNICU.Apartfromtheriskofneonatal
morbidities, moderately preterm-born
children are also more likely to have
developmental delays at preschool
age.7–9 Particularly in moderately
preterm-born children, it remains un-
clear whether these neonatal morbid-
ities are associated with the increased
risk of developmental delay.9
Inthegeneralpopulation,malegender,
small-for-gestational-age (SGA) status
at birth, decreasing gestational age,
and low maternal education increase
theriskofdevelopmentaldelay.Itmight,
therefore, be important to correct for
these biological and environmental
variables when studying the associ-
ation between neonatal morbidities
and developmental delays in moder-
ately preterm-born children.10–13 First,
insight into the impact these neonatal
morbidities have on this particular
group of preterm-born children might
help to direct future research on opti-
mizing postnatal care for this group.14
Second, it might help to predict which
children in this group might be more
likely to have developmental delays in
early childhood.
Theaimoftheauthorsofthisstudywas
to determine for moderately preterm-
born children which neonatal morbidi-
ties were associated with developmental
delay at preschool age. We hypothesized
that several neonatal morbidities would
have an association with developmental
delays in this group, independent of SGA
status,gender,gestationalage(within the
moderatelypretermrange),andmaternal
level of education.
METHODS
Population and Participants
This study was part of the Longitudinal
Preterm Outcome Project (Lollipop) on
growth and development in preterm
children.9,15,16 In a community-based
cohort of 45455 children born in 2002
and2003,allchildrenwithagestational
agebetween 32
0/7 and 35
6/7 weeks’ ges-
tation were sampled. We based the size
of our cohort on the estimates for the
numbers needed to compile growth
curvesforDutchpreterm-bornchildren,
because for that part of the Lollipop
study we needed the largest number
of children. To detect a difference in
growth restraint of 10% between term
and preterm children per week of ges-
tation, separately for boys and girls,
with a power of 80% at P =. 0 5 ,w e
needed to include 1000 moderately
preterm-bornchildren.16Inthis context,
growth restraint was deﬁned as ,10th
percentile for term children, which led
to a planned inclusion of 1000 moder-
ately preterm-born children.
All the children were included during
their regular visit to a preventive child
health care center (PCHC) at the age of
43to49months(inclusionfromOctober
2005–September 2007). At this age,
95% to 97% of all Dutch children are
seen routinely at a PCHC.17 Children
with major congenital malformations,
congenital infections, and all children
with syndromes were excluded. Even-
tually, after removal of the excluded
children, 1145 moderately preterm-born
children were included in the study.
The study was approved by the local
institutional review board, and written
informedconsentwasobtainedfromall
parents. A detailed description of how
the Lollipop study was conducted has
been described previously.9,15,16
Variables and Procedures
Parents completed several question-
naires, including the Dutch version of
the 48 months Ages and Stages Ques-
tionnaire (ASQ) before their planned
visit to the PCHC. The ASQ is a parent-
completed developmental screening
tool.18,19 Its reliability and validity have
been documented in several studies.19–22
The ASQ measures development in 5
domains: communication, ﬁne motor,
gross motor, problem-solving ability,
and personal-social functioning.18 The
scores on each domain add up to an
ASQ total-problems score. A score of
.2 SDs below the mean score for the
Dutchreferencegroupwasconsidered
to indicate developmental delay (di-
chotomous yes/no). Reliability, validity,
mean scores, and cut-off values of the
Dutch48 monthsASQversion had been
determined earlier in a larger part of
the Lollipop cohort consisting of a
sample of 1510 early and moderately
preterm-born children and 562 term-
born controls.15 For the purpose of
this study and in accordance with the
ASQ manual and American Academy of
Pediatrics recommendations, the ASQ
scores were based on the children’s
uncorrected calendar age.15,23
Data on neonatal morbidities of chil-
dren participating in this part of the
Lollipop study were collected from
hospital records, bedside charts, and
preventive child health care records.
We based our choice of neonatal mor-
bidities to be collected on general
clinical knowledge on the admission of
moderately preterm-born children and
on a search of the available literature.3
In the Netherlands, deliveries between
32 and 37 weeks’ gestation are con-
ductedinregionalhospitals.Afterbirth,
glucose values, oral intake, daily weight
gain, and jaundice are monitored ac-
cording to local protocols. Only when
the mother is critically ill or the expec-
ted birth weight of the child is ,1200 g
will mothers be admitted antenatally
to a tertiary hospital center. Whenever
a child needs mechanical ventilation
after birth or is otherwise critically ill,
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hospital and then transferred to a
tertiary NICU.
Neonatal morbidities were categorized
asbirth-related, admission-related,and
other neonatal variables. Deﬁnitions of
the variables are described in Table 1.
We did not include rare neonatal mor-
bidities (morbidities with a prevalence
of ,0.5% in moderately preterm-born
children) in the analyses because of
a lack of power to detect their effects,
however severe. Such rare morbid-
ities include high-grade intraventricular
hemorrhages, bronchopulmonary dys-
plasia, necrotizing enterocolitis, and
convulsions.
Glucose valuesaremeasured routinely
several times during the ﬁrst 24 hours
of life and longer whenever necessary
for all infants born at ,36 completed
weeks of gestation. This practice is
common in the Netherlands, even for
children staying in the maternity ward
with their mothers. In most hospitals,
glucose values were monitored by bed-
side analyses and only sent to the lab-
oratory iftheywere ,3.0 (54 mg/dL) or
2.5 mmol/L (45 mg/dL), according to
localprotocol.Childrenwithoutrecorded
laboratory data and no mention of low
plasma glucose values in discharge
letters or bedside charts were consid-
ered to have had blood glucose values
of .2.5 mmol/L (45 mg/dL).
Data on biological and environmental
variables included maternal educa-
tional level, gender, and SGA status.
Data on maternal education were col-
lected from a general parental ques-
tionnaire and data on birth weight and
gestational age were collected from dis-
charge letters, preventive child health
care records, and obstetrical data. SGA
status,asaproxyforintrauterinegrowth,
was deﬁned as a birth weight ,10th
percentile of the Dutch Kloosterman
growth curves.24
Owing to local differences among hos-
pitalsinthemannerinwhichdatawere
storedandretrieved,wecross-checked
data on both neonatal morbidities and
biologicalandenvironmentalvariables
in all available data sources.
Analyses
We ﬁrst analyzed the prevalence rates
of all birth-related, admission-related,
and other neonatal variables as well
as the prevalence rates of biological
and environmental variables of our
studygroup.Subsequently,weanalyzed
the association between all the vari-
ables and rates of abnormal ASQ total-
problems scores in univariate logistic
regression analyses. Finally, all risk
factors with univariate associations of
P , .10 were included simultaneously
in a multivariable logistic regression
model. Because we expected to ﬁnd an
association between SGA status and
several neonatal morbidities, such as
hypoglycemia, we had decided before-
hand to repeat the analyses without
the children who were SGA. For those
neonatal morbidities that had signiﬁ-
cant associations in the multivariate
analyses, we also assessed which ASQ
domainswereinvolvedandcarriedout
further investigations concerning the
variable and the children affected. All
analyses were done by using SPSS
version 18.0 (SPSS Inc, Chicago, IL).
RESULTS
Theparentsof84%(N=960)ofthe1145
participating moderately preterm-born
children completed the ASQ. The me-
dian age of these children was 46
months. Of these 960 questionnaires,
97% (N = 927) were completed within
the time window, which we had set at
43 to 49 months. We did not retrieve
data on neonatal morbidities for 10%
(N = 95) of these 927 children. This fact
waspartlyduetologisticreasons,because
TABLE 1 Deﬁnitions of Variables Concerning Neonatal Morbidities Grouped into Birth-Related,
Admission-Related, and Other Neonatal Variables, and the Deﬁnitions of the Biological
and Environmental Variables
Variable Deﬁnition
Birth-related
Low Apgar score Apgar score ,7 after 5 min
Asphyxia Asphyxia documented in the conclusion of the discharge letter
Admission-related
Not admitted Not admitted to any pediatric ward; stayed with mother in the
maternity ward
Tertiary NICU Admission to a tertiary NICU
Transportation Transfer from a regional hospital to a tertiary NICU within 72 h
after birth
Other neonatal
Circulatory insufﬁciency Inotropics, including dopamine, dobutamine, or (nor)adrenaline
Respiratory insufﬁciency
CPAP CPAP for longer than initial stabilization in the delivery room only
Ventilation Mechanical ventilation for a longer duration than initial
stabilization in the delivery room only
CPAP and/or ventilation CPAP and/or mechanical ventilation with same deﬁnitions
Apnea Apnea in discharge letter or documented on bedside charts
Caffeine Treatment with caffeine for apnea
Septicemia Both clinical symptoms and at least 1 positive blood culture result
Hypoglycemia At least 1 plasma glucose value ,1.7 mmol/L (30 mg/dL), within
ﬁrst 72 h of life
Hyperbilirubinemia Peak bilirubin value of .340 mmol/L (20 mg/dL) and/or any value
requiring phototherapy
Biological and environmental factors
SGA Birth wt ,10th percentile according to the Dutch growth curves
Male gender Male gender
Low gestational age ,34 weeks’ gestation (ie, 32
+0–33
+6 weeks)
CPAP, continuous positive airway pressure.
ARTICLE
PEDIATRICS Volume 130, Number 2, August 2012 e267
 at University of Groningen on February 10, 2013 pediatrics.aappublications.org Downloaded from we did not visit small regional hospi-
tals that were very far away from the
coordinating research center, and partly
due to missing records. The ﬁnal sample
eventually consisted of 832 children with
ASQ data within thesettimewindow and
neonatal data. The nonincluded children
in the ﬁnal sample (N = 313) more often
hadmotherswhowerenon-Dutch(15.0%
vs 5.4%, P , .001). They did not differ
signiﬁcantly concerning gender, gesta-
tional age, SGA status, maternal educa-
tion,orpercentageofmultiples(results
not shown). Demographics of the chil-
dren in the ﬁnal sample are shown in
Table 2. The prevalence rates of the
neonatal morbidities we studied ranged
from 1.1% to 46%.
Univariate Analyses
Within our total study group of 832
moderately preterm-born children, 73
(9.1%)hadabnormalASQtotal-problems
scores, as opposed to 4.2% of the term-
born children in the original Lollipop
cohort.9 Table 3 shows the results of
both the univariate and multivariate
logistic analyses. Two neonatal morbid-
ities, hypoglycemia and asphyxia, had
a positive association with develop-
mental delay as measured by the ASQ
total-problems score in the univariate
analyses; odds ratios (ORs) were 2.42
(95% conﬁdence interval [CI]: 1.23–
4.77)and3.18(CI:1.01–10.0),respectively.
Tertiary NICU admission and hyper-
bilirubinemia had positive albeit sta-
tisticallynonsigniﬁcantassociationswith
developmental delay (0.05 , P , .10).
No other neonatal morbidities were
associated with developmental delay.
Regardingbiologicalandenvironmental
risk factors, both gender and SGA were
associatedstrongly with developmental
delay, whereas maternal educational
level and a lower gestational age (within
the age range for moderately preterm-
born children) were not. Repeating our
analyses with gestational age as a con-
tinuous variable did not change our
results with respect to the effect of
gestational age.
Multivariate Analyses
As shown in Table 3, hypoglycemia re-
mained associated with an increased
risk of developmental delay as mea-
sured by the ASQ total-problems score
inthemultivariatemodel,withanORof
2.19 (CI: 1.08–4.46). Male gender and
SGA status also retained strong asso-
ciations with developmental delay in
the multivariate model. The multivari-
ate analyses without the children who
were SGA showed similar results; in
the model without the children of SGA
status, the OR of hypoglycemia for ab-
normal ASQ total scores was 2.64 (CI:
1.23–5.65).
Looking at the group of children with
hypoglycemia (N = 67) in more detail,
we found that .90% had not been ad-
mitted to a tertiary NICU, and none had
had asphyxia, circulatory insufﬁciency,
or a bilirubin value of .340 mmol/L.
Two children (3%) with hypoglycemia
were mechanically ventilated, 4 chil-
dren (6%) had a septicemia, and 8
(12%) were born SGA. Rates of SGA
status, tertiary NICU admittance, hyper-
bilirubinemia, septicemia, mechanical
ventilation, and asphyxia did not dif-
fer statistically between children with
andwithoutdocumented hypoglycemia.
Twelve of 67 children with a glucose
value ,1.7 mmol/L (30 mg/dL) had
abnormal ASQ total-problems scores;
12 of 73 children with abnormal ASQ
total-problems scores had a glucose
value ,1.7 mmol/L (30 mg/dL). In a
subanalysis, we found that ORs for ab-
normal ASQ total-problems scores in-
creased with decreasing glucose values
(Table 4). Finally, we examined the asso-
ciation between hypoglycemia and un-
derlyingASQdomains.Hypoglycemiahad
TABLE 2 Prevalence Rates for All Birth-Related, Admission-Related, Other Neonatal, Biological,
and Environmental Variables for Different Gestational Groups
Variable 32–35 wk,
N = 832
32–33 wk,
N = 268
34–35 wk,
N = 564
Na % N % N %
Birth-related
Low Apgar score 32 3.7 14 5.2 18 3.2
Asphyxia 17 2.0 8 3.0 9 1.6
Admission-related
Not admitted to a pediatric ward 5 0.6 0 0 5 0.9
Tertiary NICU 119 14.3 74 27.6 45 8.0b
Transportation 37 4.4 22 8.2 15 2.7b
Other neonatal
Circulatory insufﬁciency 25 3.0 12 4.5 13 2.3
Respiratory insufﬁciency
CPAP (0–13 d) 139 16.7 82 30.6 57 10.1b
Ventilation (0–23 d) 62 7.5 40 14.9 22 3.9b
CPAP and/or ventilation 153 18.4 91 34.0 62 11.0b
Apnea 193 23.3 119 44.4 74 13.2b
Caffeine 94 11.4 74 27.6 20 3.6b
Septicemia 30 3.6 17 6.3 13 2.3b
Hypoglycemiac 67 8.1 24 9.0 43 7.7
Hyperbilirubinemiad 361 46.4 147 55.1 214 38.0b
Biological and environmental factors
SGA (,10th percentile) 76 9.1 25 9.3 51 9.0
Male gender 471 56.6 145 54.1 326 57.8
Low maternal education 246 29.7 91 34.1 155 27.7b
CPAP, continuous positive airway pressure.
a All variables: #9 children with missing data.
b P , .05 for differences between both gestational groups in x
2 analysis.
c At least 1 recorded plasma glucose value ,1.7 mmol/L (30 mg/dL). Range, lowest recorded value: 0.4–6.4 mmol/L.
d Peak bilirubin value of .340 mmol/L (20 mg/dL) or any value requiring phototherapy. Range, highest recorded value:
34–421 mmol/L.
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associations with all 5 underlying ASQ
domains, as shown in Table 5.
DISCUSSION
The authors of this study demon-
s t r a t e dt h a ti nag r o u po fm o d e r a t e l y
preterm-bornchildren,onlyhypoglycemia
was associated with parent-reported
developmental delay at preschool
age, controlling for SGA status and
gender. No other neonatal morbid-
ities we studied were associated
with developmental delay in this
group.
Ourﬁndingthatonlyhypoglycemiawas
associated with an increased devel-
opmental risk in moderately preterm-
born children was unexpected. A
documentedglucosevalue,1.7mmol/L
(30 mg/dL) was rather common (8.1%)
a n di n c r e a s e dt h er i s ko fd e v e l o p -
mental delay from 9.1% to almost
20%. There is no consensus among
pediatricians on the absolute thresh-
old values for hypoglycemia thatwill
lead to brain injury.25–28 There also
is no consensus on speciﬁco p e r a -
tional thresholds for different gesta-
tionalagesbelowwhichextrameasures
to prevent hypoglycemia should be
undertaken.25,26 There is consider-
able debate on the effect of short-
lasting low plasma glucose levels at
higher values than 1.7 mmol/L, that
is, in the range between 1.7 and 2.5
mmol/L(30–45mg/dL).25–27Wechose
arelativelylowcut-offpointtoenable
us to study even short periods of
hypoglycemia.
Hypoglycemiaisonlyaproxyforenergy
failure in the brain. The effect of hypo-
glycemia on the brain, even if it occurs
only during a short period, also de-
pends on many other factors. These
factors include cerebral blood ﬂow,
cerebral glucose utilization, and the
presence of alternative substrates such
as lactate and ketone bodies.25–29
Comorbidity among the children with
hypoglycemia was not increased sig-
niﬁcantly, suggesting that they were
not the sicker children. Moreover, ex-
cludingchildrenofSGAstatusfromthe
analyses did not change our results.
The effects on development of hypo-
glycemia in moderately preterm-born
children seemed to be due to the hypo-
glycemia in itself. Furthermore, risk of
developmental delay increased with de-
creasing glucose values, with a steeper
incline below 1.7 mmol/L (30 mg/dL),
suggesting an increased risk of brain
injury below this value. There are rel-
atively few studies published on the
effect of neonatal hypoglycemia on
development in early childhood. In a
systemic review on this subject, the
authors concluded that no valid esti-
mate of the effect of neonatal hypogly-
cemia on development could be given
based on the 18 studies included in
their review.30
TABLE 3 ORs, 95% CIs, and P Values for Abnormal ASQ Total-Problems Scores for Birth-Related
and Admission-Related or Other Neonatal Variables and Biological and Environmental
Variables
Variable Univariate Analyses Multivariate Analysesa
OR (CI) P OR (CI) P
Birth-related
Low Apgar score 1.11 (0.33–3.75) .87 ——
Asphyxia 3.18 (1.01–10.0) .05 2.67 (0.74–9.60) .13
Admission-related
Not admitted to a pediatric ward 0.81 (0.10–6.59) .85 ——
Tertiary NICU 1.74 (0.96–3.15) .07 1.22 (0.61–2.42) .57
Transportation 1.26 (0.43–3.15) .67 ——
Other neonatal
Circulatory insufﬁciency 0.47 (0.05–3.05) .38 ——
Respiratory insufﬁciency
CPAP 0.85 (0.44–1.67) .65 ——
Ventilation 1.04 (0.45–2.64) .84 ——
CPAP and/or ventilation 0.76 (0.39–1.48) .65 ——
Apnea 0.85 (0.44–1.67) .65 ——
Caffeine 0.76 (0.39–1.48) .41 ——
Septicemia 1.56 (0.53–4.60) .42 ——
Hypoglycemiab 2.42 (1.23–4.77) .01 2.19 (1.08–4.46) .03
Hyperbilirubinemiac 1.52 (0.94–2.46) .09 1.48 (0.89–2.46) .13
Biological and environmental factors
SGA (,10th percentile) 3.30 (1.78–6.12) ,.001 2.62 (1.36–5.05) ,.001
Male gender 3.54 (1.94–6.46) ,.001 3.12 (1.70–5.75) ,.001
Low gestational aged 0.95 (0.57–1.60) .85 ——
Low maternal education 1.31 (0.79–2.18) .30 ——
CPAP, continuous positive airway pressure.
a All variables with univariate associations at P , .10 were entered in the multivariate model simultaneously.
b At least 1 plasma glucose value ,1.7 mmol/L (30 mg/dL).
c Peak bilirubin value of .340 mmol/L (20 mg/dL) or any value requiring phototherapy.
d Low gestational age within the study group; that is, 32
0/7 to 33
6/7 weeks’ gestation.
TABLE 4 ORs, 95% CIs, and P Values for Abnormal ASQ Total-Problems Scores for Different Ranges
of Hypoglycemia
Variable N OR CI P
Glucose value ,1.1 mmol/L (20 mg/dL) 25 3.04 1.03–9.00 .045
Glucose value of 1.1–1.7 mmol/L (20–30 mg/dL) 42 2.50 0.98–6.40 .055
Glucose value of 1.7–2.2 mmol/L (30–40 mg/dL) 120 1.40 0.66–3.00 .38
Glucose value of 2.2–2.8 mmol/L (40–50 mg/dL) 109 1.31 0.59–2.92 .41
TABLE 5 ORs, 95% CIs, and P Values for
Abnormal ASQ Domain Scores for
Hypoglycemia
ASQ Domain OR (CI) P
Fine motor 1.7 (0.81–3.61) .16
Gross motor 2.0 (0.87–4.71) .10
Communication 1.7 (0.81–3.40) .16
Problem-solving 2.1 (0.94–4.37) .07
Personal-social 2.2 (0.93–5.05) .08
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strate of hypoglycemia on the brain
are rare and derive mostly from adult
studies, animal studies, or studies on
term-born infants.27,28 MRI ﬁndings in
thesefewstudieshaveshownthatboth
diffuse cortical and subcortical inju-
ries, hemorrhages, infarction, and basal
ganglia and thalamus abnormalities are
relatedtohypoglycemia.27,28Ourﬁndings
on the effects of hypoglycemia on de-
velopmental delay across all 5 devel-
opmental domains measured by the ASQ
are in agreement with these ﬁndings of
injuries in a wide range of cerebral
regions.
The high risk for hypoglycemia in mod-
erately preterm-born infants can be
explained by the fact that in comparison
withhealthyterm-borninfants,theyhave
less glucose stores, less alternative
substrates, and less well-developed hor-
monal counter-regulatory mechanisms
to sustain adequate glucose levels after
birth.25–29 They also have more difﬁcul-
ties in starting to feed orally and in
achieving adequate feedings than term-
born infants do.3,5 Moreover, in contrast
to early preterm-born infants, moder-
atelypreterm-borninfants donot always
routinely receive intravenous glucose
infusions after birth.
In our moderately preterm-born study
group, we found no association between
othercommonneonatalmorbiditiessuch
as respiratory insufﬁciency, circulatory
insufﬁciency, and septicemia and devel-
opmental delay. This ﬁnding is contrary
to our hypothesis and in contrast with
ﬁndings on early preterm-born children,
for whom several of these neonatal
morbidities were linked to an increased
risk of developmental delay.31–33 The dif-
ferences in the effects of these neonatal
morbidities on developmental delays in
bothgroupsmightbeduetothefactthat
the severity of several neonatal morbid-
ities is usually lower in the moderately
preterm-born group. No child was venti-
lated for .2 weeks, and bilirubin values
of .340 mmol/L (20 mg/dL) were rare.
Furthermore, we speculate that the
brain of moderately preterm-born chil-
dren is perhaps more resilient toinjury
caused by neonatal morbidities than the
brain of early preterm-born children.
The strengths of our study were the
community-based approach and the
large number of children who partici-
pated. We also recognize several limi-
tations of our study. We measured
developmental outcome with a parent-
completed screening tool instead of
submitting the children to extensive
neuropsychological tests. Neverthe-
less, developmental screeners are con-
sidered to be reliable measures for
identifying developmental problems
in high-risk populations.34 As e c o n d
limitation was the retrospective de-
sign for collecting data on neonatal
morbidities. It is possible that for
some children, hypoglycemia had not
been measured according to the na-
tional guidelines or had been recorded
in sources we were unable to trace.
A third limitation concerned the low
prevalence of some of the risk fac-
tors, such as asphyxia, circulatory
insufﬁciency, not being admitted to
neonatal care, and intraventricular
hemorrhages.Thislowprevalenceleads
to a relatively low power to detect
differences in developmental outcome.
Still larger population-based studies
are needed to estimate the effect of
such severe, but rare, neonatal mor-
bidities on risk of developmental de-
lay. Finally, more children who were
not included in the ﬁnal analyses had
mothers born outside the Netherlands.
The latter children are unlikely to
have had different neonatal morbid-
ities. Furthermore, all children born
in the Netherlands get equal medical
care at birth regardless of the in-
surance of their parents. We therefore
think these differences in rates of moth-
ers born outside the Netherlands will
not have inﬂuenced our results.
Our study may have important impli-
cations. We were surprised to ﬁnd that
8.1% of the moderately preterm-born
c h i l d r e nw es t u d i e dh a da tl e a s t1d o c u -
mented glucose value of ,1.7 mmol/L
(30 mg/dL), which occurred despite the
guidelines to prevent hypoglycemia in
this group. These guidelines include
recommendations to monitor glu-
cose regularlyduringtheﬁrst 24 hours,
and administering early, frequent en-
teral feedings. Controlled, prospective
studies with interventions aiming at
enhanced prevention of severe hy-
poglycemia in moderately preterm-
born children are needed to conﬁrm
thatthechanceofdevelopmentaldelay
can be modiﬁed by stricter glucose
control.35 The next implication is that
our results might help to further un-
ravel the complex cascade of biologi-
cal, environmental, prenatal, perinatal,
and postnatal events that might all
lead to developmental delay in mod-
erately preterm-born children.2,10,12
We found that the effects of SGA sta-
tus and male gender were more impor-
tantthan all the neonatal morbidities
we examined. Our study, therefore,
does not support the view that neo-
natal morbidities have a large inﬂu-
ence on developmental outcome in the
group of moderately preterm-born
children.
CONCLUSIONS
Hypoglycemiaaftermoderately-preterm
birth is associated with an increased
risk of parent-reported developmen-
tal delayat age4. Strictermonitoring
andtimelytreatmentofhypoglycemia
after birth might beneﬁtt h el a r g e
group of moderately preterm-born
children.
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